Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary ...

While smoking remains the leading risk factor for COPD, non-smokers should be aware of other environmental and occupational ...

Higher dietary magnesium intake is associated with a reduced risk of frailty in patients with chronic obstructive pulmonary ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Chronic Obstructive Pulmonary Disease, or COPD, is a severe lung condition that affects over 14 million adults in the United States, with women being particularly vulnerable. Dr. Chidinma Chima ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...